Technological breakthroughs in Omic technologies have led to a new wave of molecule biomarkers and clinical insights. Now, technology platforms from proteomics, metabolomics, and epigenomics are becoming tested as frequently as genetics and offering even more insight for clinicians to use for their patients. This growth is most prevalent in the field of epigenetic methylation.
DNA methylation is a biomarker which relates to DNA expression. However, unlike genetic testing, this marker is changeable by almost every factor in our lives including nutrition, fitness, environmental factors, medications, aging and disease. In recent years, this has become popular in the setting of biological age testing. As age is the biggest risk factor for almost every disease, DNA methylation based clocks have given us the most accurate tools to quantify this process and treat the aging process preventatively.
In this course, Dr. Jessica Lasky-Su from Harvard Medical School and Brigham and Women’s Hospital will elaborate on the developments which have been made to epigenetic age clocks and discuss OMICm Age. OMICm age is the most advanced epigenetic clock which has been developed from a novel multi-omic dataset. Dr. Lasky-Su will talk about how the improvements in this clock make application in clinical medicine much more feasible and improve on limitations of previous age clocks.
DNA methylation is also expanding beyond the field of aging. Over the past few years, algorithms using DNA methylation data have been developed to predict disease, predict clinical response to common drugs such as metformin and Semaglutide, predict smoking and drinking status and even predict death. Ryan Smith, founder of TruDiagnostic, will address other ways to use methylation analysis in your clinic to improve the way you treat patients.
This conference will be “one of a kind” in providing insights into this rapidly evolving field from both the research and clinical perspective. Any health care provider interested in the newest and most accurate tools to measure aging and many other disease conditions in a single test will not want to miss this conference. The focus of this conference will be on delivering useful information that can be translated into clinical practice and patient education. You will not want to miss this program.